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INTRODUCTION 
 
The chronological age, defined as the time elapsed since 
birth, fails to be an accurate indicator of the rate of the 
aging process [1], which starts at adult age and finishes 
at the end of the life of each subject. This is due to the 
heterogeneity that aging shows in the diverse members 
of a population. This phenomenon led to the concept of 
“biological age”, which estimates how well an 
individual functions in comparison with others of the 
same chronological age [2]. Given that biological age is 
a better indicator than chronological age of the health, 
remaining healthy life span and active life expectancy 
of each subject [2-4], its determination is very relevant. 
However, despite its simple definition, quantification of 
the biological age is a difficult task. Many studies have 
been carried out trying to obtain the most appropriate 
parameters for determining biological age and have 
been mainly focused on both physiological (respiratory 
function, systolic arterial tension, hematocrit…) as well 
as   on  biochemical  (albumin,  cholesterol,  blood  urea  
 
nitrogen…) markers [5-10]. Moreover, other markers 
such as genetic (telomere length) [11] or epi-genetic 
(DNA methylation) [12] have also been proposed. 
Nevertheless, despite different sets of markers being 
proposed in these studies, none of them have been 
validated. Therefore, the subject is still incomplete and 
more research should be carried out. 
 
Most work on biological age has not included 
parameters of the immune system, which is a homeo-
static system that contributes to the appropriate function 
of the organism. It is well known that with aging there 
is an increased susceptibility to infectious diseases, 
autoimmune processes and cancer, which indicates the 
presence of a less competent immune system, exerting a 
great influence on age-related morbidity and mortality 
[13, 14]. Since it has been demonstrated that the 
functioning of the immune system is an excellent 
marker of health [15, 16] and given that several age-
related changes in immune functions have been linked 
to longevity [17-19] whereas others have been shown to 
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ABSTRACT 
 
Chronological age  is not a good  indicator of how each  individual ages and thus how to maintain good health.
Due to the  long  lifespan  in humans and the consequent difficulty of carrying out  longitudinal studies,  finding
valid biomarkers of the biological age has been a challenge both for research and clinical studies. The aim was
to  identify and validate several  immune cell function parameters as markers of biological age. Adult, mature,
elderly and  long‐lived human volunteers were used. The chemotaxis, phagocytosis, natural killer activity and
lymphoproliferation  in neutrophils and  lymphocytes of peripheral blood were analyzed. The  same  functions
were measured  in peritoneal  immune cells from mice, at the corresponding ages (adult, mature, old and  long
lived)  in a  longitudinal study. The results showed that the evolution of these functions was similar  in humans
and mice, with a decrease  in old  subjects.   However,  the  long‐lived  individuals maintained values  similar  to
those in adults. In addition, the values of these functions in adult prematurely aging mice were similar to those
in chronologically old animals, and they died before their non‐prematurely aging mice counterparts. Thus, the
parameters studied are good markers of the rate of aging, allowing the determination of biological age.  
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be predictive of mortality [20-22], the aim of the present 
study was to determine if some immune functions could 
be useful as markers of biological age and therefore as 
predictors of longevity. 
 
In order to validate a potential set of parameters as 
markers of biological age, it is necessary to confirm that 
the levels shown in particular subjects reveal their real 
health and senescent conditions and consequently, their 
rate of aging. This has to be demonstrated by meeting 
two requirements. The first is that if an adult individual 
shows values characteristic of a chronologically old 
individual, he/she should die prematurely. The second is 
that a long-lived individual, known to have experienced 
healthy aging, should have a value of these biomarkers 
similar to that of an adult [16]. The first requisite can 
only be confirmed in experimental animals, given that it 
is a difficult task to follow-up human subjects 
throughout the whole aging process due to their long 
life span. Thus, mice were chosen for our study, which 
show a mean longevity of about 2 years. Previous 
studies from our group have proposed a murine model 
of premature aging based on an inappropriate reactivity 
to stress. Thus, prematurely aging mice (PAM) are 
identified by their poor response in a simple T-maze 
test. These PAM at the adult age showed a premature 
immunosenescence that was accompanied by a shorter 
lifespan compared to their counterpart non prematurely 
aging mice (NPAM) of the same sex and chronological 
age [23, 24]. The second requirement can be confirmed 
in both humans (centenarians) and experimental animals 
such as extremely long-lived mice. 
 
Among all the possible functions of immune cells, we 
have focused on the ones that are the most relevant in 
the immune response and are known to experience an 
age-related decrease [25]. In phagocytes, their ability to 
migrate towards the focus of infection (chemotaxis) and 
their capacity to ingest foreign particles (phagocytosis); 
in natural killer (NK) cells, their capacity to destroy 
tumor cells and in lymphocytes, their ability to migrate 
towards the site of antigen recognition (chemotaxis) and 
to proliferate in response to mitogens (lympho-
proliferation).  
 
Thus, in order to validate the above mentioned immune 
functions as markers of biological age and predictors of 
longevity, these functions were studied in leukocytes 
isolated from peripheral blood of human subjects in a 
cross-sectional study, from their 30s until their 100s. In 
addition, the same functions were analyzed in leukocytes 
obtained from peritoneum of mice without killing them, 
enabling a longitudinal study to be performed, starting at 
the adult age and following each animal until its death. 
The same functional parameters were also assessed in 
peritoneal leukocytes from adult PAM and NPAM.   
RESULTS 
 
In this study, in order to identify and validate several 
functions of immune cells as markers of biological age 
and predictors of longevity, their age-related changes 
were measured in leukocytes from both humans and 
mice. 
 
The results obtained in the functions studied in isolated 
human blood neutrophils (chemotaxis and phagocytic 
capacities) and mononuclear cells, principally 
lymphocytes and NK cells (the anti-tumor cytotoxic 
activity of NK cells as well as the chemotaxis and 
proliferative response of lymphocytes to mitogens), 
obtained from adult, mature, old and long-lived subjects 
are shown in Fig. 1. Neutrophil chemotaxis (Fig. 1.A1) 
and phagocytosis (Fig. 1.B1), as well as the activity of 
NK cells (Fig. 1.C1), lymphocyte chemotaxis 
(Fig.1.D1) and proliferative response (Fig.1.E1) showed 
lower values (P<0.001) in old individuals in 
comparison to those in adults. These lower values were 
also shown in mature subjects (P<0.001 in neutrophil 
chemotaxis and phagocytosis; P<0.01 in chemotaxis of 
lymphocytes and P<0.05 in NK activity). In addition, to 
further explore the relationship between the age and the 
immune parameters analyzed, Pearson´s correlations 
were carried out (Table 1). The results showed 
statistically significant negative correlations (P<0.001) 
between the age of the subjects and the values of all the 
immune functions evaluated. 
 
In peritoneal leukocytes from mice these immune 
functions, analyzed at the corresponding ages to 
humans, but in a longitudinal study, changed in a 
similar manner (Fig.1A2, B2, C2, D2 and E2). Thus, the 
results showed a significant decrease (P<0.001) in the 
values of all the functions studied at old age with 
respect to those when they were adults. This decrease 
was also appreciated at mature age (P<0.001 in 
phagocytosis of macrophages and lymphoproliferation, 
P<0.01 and P<0.05 in chemotaxis of macrophages and 
lymphocytes, respectively). Therefore, the results 
revealed that these immune functions of murine 
peritoneal leukocytes present a similar age-related 
evolution to those in human blood immune cells. 
 
Considering the state of these functions in subjects 
which reach a high longevity, and consequently have 
attained successful aging, both humans and mice 
showed in general, more similar values to those 
observed at adult age than to those at old age, primarily 
in mice (Fig. 1). Thus, human centenarians showed 
higher values in all the functions analyzed with respect 
to old subjects (P<0.05 in neutrophil chemotaxis and 
lymphoproliferation; P<0.001 in neutrophil phago-
cytosis, NK activity and lymphocyte chemotaxis).  
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Figure  1.  Age‐related  changes  in  immune  functions  in  peripheral  blood  leukocytes  from  humans  and  in
peritoneal leukocytes from mice. (A) Phagocytic Index: number of latex beads ingested per 100 human neutrophils (A.1) or
mouse macrophages  (A.2  and A.3);  (B)  Chemotaxis  Index:  number  of  phagocytes  on  the  filter,  human  neutrophils  (B.1)  or
mouse macrophages  (B.2 and B.3);  (C) NK cytotoxic activity  (percentage of  lysis of tumor cells) of human  leukocytes  (C.1) or
mouse leukocytes (C.2 and C.3). (D) Chemotaxis Index: number of human lymphocytes on the filter (D.1) or mouse lymphocytes
(D.2 and D.3);  (E) Percentage of proliferation of  lymphocytes  in response to the mitogen Phytohaemagglutinin  in the case of
humans  (E.1) and  in  response  to Concanavalin A  in  the  case of mice  (E.2 and E.3). The  results  corresponding  to peritoneal
leukocytes from adult prematurely‐aging mice (PAM) and non‐prematurely‐aging mice (NPAM) are shown in A.3, B.3, C.3, D.3,
and E.3. A: Adult; M: Mature; O: Old; L: Long‐Lived; a: P < 0.05; aa: P < 0.01; aaa: P < 0.001 with respect to the value in adults. b:
P < 0.05; bb: P < 0.01; bbb: P < 0.001 with respect to the value in mature individuals. c: P < 0.05; cc: P < 0.01; ccc: P < 0.001 with
respect to the value in old subjects. d: P < 0.05; dd: P < 0.01; ddd: P < 0.001 with respect to the value in NPAM. 
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Comparing to adults, human centenarians showed a 
higher phagocytosis (P<0.001) but lower neutrophil 
chemotaxis (P<0.001), NK activity and lympho-
proliferation (P<0.05), whereas no statistically 
significant differences were found between centenarians 
and adults in lymphocyte chemotaxis. Long-lived mice 
also showed a significant increase in all the functions 
analyzed with respect to when they were old (P<0.05 in 
macrophage phagocytosis, NK activity and lympho-
proliferation; P<0.001 in macrophage and lymphocyte 
chemotaxis). No statistically significant differences 
were found in mice between when they are adult and 
long-lived in macrophage chemotaxis and phagocytosis, 
NK activity and lymphocyte chemotaxis,  whereas long- 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
lived mice showed a decrease in lymphoproliferation 
(P<0.05) with respect to the adult age. 
 
With regard to the model of premature aging in mice, 
chronologically adult PAM showed lower values in all 
the immune functions analyzed (P<0.001) in relation to 
their adult NPAM counterparts (Fig. 1.A3 to Fig. 1.E3). 
Furthermore, in comparison to adult mice from the 
longitudinal study, PAM also showed significantly 
lower values (P<0.001) in chemotaxis of macrophages, 
NK activity and lympho-proliferation, as well as in 
phagocytosis (P<0.01). The values in PAM were 
similar to those observed in chronologically old mice. 
Moreover, PAM exhibited a shorter life span (P<0.01) 
than NPAM (Fig. 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Pearson´s correlation coefficients between the immune 
functions  analyzed  in  human  peripheral  blood  leukocytes  and 
the age of the subjects.  
 
  CORRELATION COEFICIENT (r) P 
Neutrophil Chemotaxis -0.632 0.000 *** 
Neutrophil Phagocytosis -0.711 0.000 *** 
Natural Killer Activity -0.589 0.000 *** 
Lymphocyte Chemotaxis -0.551 0.000 *** 
Lymphoproliferation -0.486 0.000 *** 
 
Figure  2.  Kaplan‐Meier  cumulative  survival  of  prematurely  aging mice:  PAM
(solid line) and non‐prematurely aging mice: NPAM (dashed line). **: P < 0.01. 
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DISCUSSION 
 
Many efforts have been made to define the best means 
for measuring biological age, but considerable 
disagreement exists concerning the logical strategy for 
the selection criteria of the corresponding biomarkers. 
For example, cross-sectional designs can only indicate 
differences between age groups at a specific point in 
time. Therefore, in order to conclude that changes have 
occurred because of aging phenomena, longitudinal 
designs are needed [7].  In the present study, the 
selection of biomarkers of aging has been based on both 
cross-sectional data in humans (because it is very 
difficult to carry out a longitudinal study throughout 
aging in our species) and longitudinal data in mice. To 
our knowledge, this is the first study that combines 
results from humans and experimental animals as well 
as showing the results of a longitudinal study performed 
in mice, initiated at the adult age of 40 weeks 
(equivalent to 40 years in humans) until the natural 
death of the animals.  
 
The immune system is relatively immature at birth and 
completes its development at the end of growth, which 
is during the second decade of life in human beings 
[26]. The brain is not fully mature until the early 20s 
[27, 28] and some hormones reach their peak at 25 
years of age [29]. For these reasons, the decision to 
begin the study at the age of 30 years in humans, and 
the corresponding age in mice, was taken in order to 
ensure that all of the adult subjects had already 
developed a mature and competent immune system and 
had already begun the aging process. 
 
With respect to the biological age markers chosen, these 
were relevant functions of the immune system.  This 
physiological system is a complex mechanism of 
defense of the organism against the continual infectious 
processes and cancers to which we are submitted since 
birth. Moreover, this system is also involved in 
repairing the damage, and maintaining and restoring 
tissue integrity [30, 31]. To carry out all these functions, 
the immune system cells, phagocytes and lymphocytes, 
show a wide range of capacities, which constitute the 
so-called "immune response". However, the defensive 
role of the immune system is compromised during the 
aging process, since with the advance of age the number 
of tissue injuries in the body increases as well as the 
infection processes and cancers and consequently, the 
mechanisms of defense are more frequently required. In 
fact, almost every component of the immune system 
undergoes striking age-associated restructuring, leading 
to changes that may include enhanced as well as 
diminished functions. Some of these age-associated 
changes in immune functions, which constitute the 
denominated immunosenescence, have been linked to 
longevity both in mice [25] and in humans [15-18, 32]. 
In this sense, the immune function parameters are the 
best choice to be biomarkers of biological age.  
 
Although both innate and adaptive immunity suffer age-
related changes, most studies in humans and mice have 
focused on the severe deterioration of adaptive immune 
response with age. Thus, aspects of innate immunity 
most typically studied such as phagocytosis and NK cell 
cytotoxicity, have been considered to remain relatively 
unaffected [17]. An aspect of the innate immune 
response such as mobility to the focus of infection 
following a chemical gradient (chemotaxis) has been 
hardly studied in this context. However, more recent 
work has shown that innate immunity is also very 
affected by aging [25, 33]. For this reason, and even 
though a few parameters of adaptive immunity have 
allowed the definition of the “immune risk phenotype” 
[19, 34], since they are very limited and have not been 
validated as markers of biological age, in the present 
study several relevant functions of innate immunity 
such as chemotaxis, phagocytosis and NK activity as 
well as other functions of adaptive immunity such as 
proliferation of lymphocytes, were chosen. Age-related 
changes in immune cell populations were not analyzed 
in this study. Even though the effectiveness of an 
immune response could be influenced by immune cell 
population changes (in terms of frequency or counts), 
the study of these changes could give incomplete 
information about the immune response capacity. Thus, 
an increase in the number of a specific immune cell type 
does not imply a better performance of these cells, but 
rather the opposite. In fact, it has been shown that there 
is an age-related increase in the number of CD3-
CD56(+) NK cells, which has been explained by a 
compensatory mechanism towards the age-related loss 
of the  functional capacity  of these cells [35, 36]. 
 
This is the first study in which these functions have 
been validated as indicators of an individual´s health 
and biological age. Thus, they were preserved in long-
lived individuals (both human centenarians and 
extremely long-lived mice), which are expected to have 
withstood the detrimental effects of the aging process 
better than those individuals who do not live to extreme 
old age. In addition, mice, which at the adult age 
already have similar immune function values to those of 
chronologically old animals, achieve a shorter lifespan. 
Although this second aspect has not been addressed in 
humans, since the age-related evolution of these immune 
functions is similar in both mice and humans, it can be 
assumed that those humans showing immune parameters 
at the levels of older subjects have a higher biological age 
and consequently they will not live so long. In fact, the 
present study reveals that there is an age-related decline 
in the immune function parameters analyzed in both 
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human blood neutrophils and lymphocytes, as well as in 
peritoneal macrophages and lymphocytes from mice, 
with the lowest values in elderly humans (65-79 years of 
age) and old mice (72 weeks of age). This age-related 
decline was further supported by the strong negative 
correlation coefficients obtained in humans. 
 
Recent studies have suggested that a big cohort of 
parameters is needed in order to accurately estimate the 
biological age [37]. The present study demonstrates that 
the five immune functions analyzed are valid enough to 
be used as indicators of an individual´s health and 
remaining lifespan and therefore, are proposed as 
markers of biological age. In addition, these immune 
function parameters can be useful for the early 
identification of accelerated aging in humans, which 
may offer opportunities for prevention of age-related 
diseases and premature death. Furthermore, as the 
maintenance of health and consequently the rate of 
aging, principally depend on environment and lifestyle 
[16, 38], several strategies such as nutritional (caloric 
restriction or antioxidant administration) and physical 
exercise interventions, which can improve the immune 
response [39], are increasingly being used to slow down 
the aging process. However, as there is no accurate way 
of testing their effectiveness, the immune functions 
proposed in the present study will also be an aid for 
monitoring the effectiveness of such interventions. 
Moreover, due to the easy obtainability of the samples 
in which the immune parameters can be studied, our 
proposal will be very helpful in controlling health and 
promoting a healthy longevity.   
 
MATERIALS AND METHODS 
 
Subjects 
 
A total of 140 human volunteers (78 women; 62 men) 
between 30-103 years old were studied and divided into 
four different experimental groups: adult (30-49 years-
old; 18 women and 17 men), mature (50-64 years-old; 18 
women and 17 men), old (65-79 years-old; 18 women 
and 17 men) and long-lived subjects (90-103 years-old; 
24 women and 11 men). All the participants are members 
of the Spanish population. The inclusion criteria 
were that the subject should be in a healthy condition 
(absence of pathology or findings of clinical significance 
in general laboratory parameters). All participants have 
given written consent for the use of their blood samples 
for the purposes of this study. All procedures were 
carried out according to the Declaration of Helsinki.  
 
Experimental animal 
 
Female ICR/CD1 ex-reproductive mice (Mus musculus) 
were used in this study. Animals were purchased from 
Janvier Labs (Germany) at the adult age (32±4 weeks), 
and were placed and acclimatized in the Animal Facility 
at the Faculty of Biology (UCM). Mice were housed at 
4-5 per cage and maintained in standard laboratory 
animal conditions for pathogens, temperature (22±2ºC) 
and humidity (50-60%), on a 12/12 h reversed 
light/dark cycle (lights on at 20:00 h) to avoid circadian 
interferences. Mice had access to tap water and standard 
pellets (Panlab, Spain) ad libitum.  One group of 
animals (n=40) was used for the longitudinal study. The 
collection of peritoneal suspensions was at the adult 
(40±4 weeks; n=38), mature (56±4 wk; n=25), old 
(72±4 wk; n=15) and long-lived (96±4 wk; n=11) ages. 
Another group of animals were classified as 
prematurely aging mice (PAM) (n=10) and non-
prematurely aging mice (NPAM) (n=10) according to 
their different behavior in a T-maze, as previously 
described [23, 24]. After their classification, the 
collection of the peritoneal suspensions was only at the 
adult age (40±4 wk). All the experiments were approved 
by the Experimental Animal Committee of Complutense 
University of Madrid (UCM) (Spain) and were in 
accordance with the guidelines of the European 
Community Council Directives ECC/566/2015.  
 
Classification of mice according to a model of 
premature aging: T-maze test 
 
One week after their arrival and acclimation in the 
Animal Facility of the Faculty of Biology (UCM), one 
group of adult female ICR/CD1 mice (33±4 weeks) 
were classified as PAM and NPAM according to their 
different behavior in a T-maze, as previously described 
[23, 24]. This T-shaped maze essentially consists of 
three arms made of wood, whose internal surfaces are 
covered with black methacrylate. The inside dimensions 
of each arm are 10 cm wide, 25 cm long, and 10 cm 
high. The floor is made of 3 mm-thick cylindrical 
aluminum rods placed perpendicularly to the side walls. 
The test is performed by holding the mouse by the tip of 
its tail and placing it inside the “vertical” arm of the 
maze with its head facing the end wall. Its performance 
is evaluated with a chronometer to measure the time the 
animal takes to cross the intersection of the three arms 
with both hind legs. This test was carried out four times, 
once a week, to sort the PAM (that required > 10 s to 
complete exploration of the first arm at each test) from 
the NPAM (that completed the exploration in < 10 s in 
each test). Animals showing an intermediate response to 
the T-maze were removed from the study. Thus, we had 
two groups of animals: one group including the NPAM 
population (n=10) and another including the PAM 
population (n=10). This test was always performed 
between 09:00 and 11:00 h (to avoid circadian 
variations) under red light.  
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Collection of human blood samples and isolation of 
neutrophils and lymphocytes 
 
Peripheral blood samples (10 mL) were collected using 
vein puncture and sodium citrate-buffered Vacutainer 
tubes (BD Diagnostic, Spain), between 9:00 to 10:00 
a.m. to avoid circadian variations in immune para-
meters. Neutrophils and lymphocytes cells were isolated 
from whole blood following a previously described 
method [40], using 1.119 and 1.077 density Hystopaque 
(Sigma-Aldrich, Spain) for neutrophil and lymphocyte 
separation, respectively. Collected cells (95% of 
viability determined using trypan blue staining) were 
adjusted to the corresponding final concentrations for 
the development of each assay. 
 
Collection of murine peritoneal leukocytes 
 
Murine peritoneal suspensions were collected between 
8.00 am and 10.00 a.m., to minimize circadian 
variations of the immune parameters studied. The use of 
peritoneal cell sample has the main advantage of not 
having to sacrifice the animals. Without using 
anesthesia, mice were held by cervical skin, the 
abdomen was cleansed with 70% ethanol (Sigma-
Aldrich), and 2 ml of sterile Hank´s solution, previously 
tempered at 37ºC, was injected into the peritoneum 
[25]. After massaging the abdomen, approximately the 
80% of injected volume was recovered by the needle 
employed for the injection of Hank´s. Leukocytes from 
peritoneal suspensions were identified by their 
morphology (macrophages or lymphocytes) and 
quantified (number of cells/mL) in Neubauer chambers 
using optical microscopy (x40). Cellular viability, 
which was routinely checked before and after each 
experiment by the trypan blue (Sigma-Aldrich) 
exclusion test, was higher than 95±1% in all cases. The 
following studies were performed using unfractionated 
peritoneal leukocytes to better reproduce the in vivo 
situation. The peritoneal suspensions were adjusted to a 
specific number of macrophages, lymphocytes or total 
leukocytes, depending on the parameter analyzed as 
described in the corresponding section. 
 
Chemotaxis 
 
The induced mobility or chemotaxis of neutrophils, 
macrophages and lymphocytes was evaluated according 
to the method previously described [25, 40]. Cell sus-
pensions were deposited in the upper compartment of a 
Boyden chamber separated by a filter of polycarbonate 
(3 µm of diameter; Merl-Millipore, Ireland). The 
number of cells (neutrophils, macrophages and 
lymphocytes) that migrated toward the chemoattractant 
agent, formyl-Met-Leu-Phe (fMLP, 10-8 M, Sigma-
Aldrich), deposited in the lower compartment of the 
chamber, was counted in the lower face of the filter that 
separates the two compartments of the chamber. This 
number was expressed as Chemotaxis Index.  
 
Phagocytosis 
 
Phagocytosis of inert particles (latex beads, 1.1 μm 
diameter, Sigma-Aldrich) was assayed in phagocytes 
(neutrophils and macrophages) following a method 
previously described [25, 40]. Cell suspensions were 
incubated on migration inhibition factor (MIF) plates 
(Kartell, Noviglio, Italy) for 30 min at 37 ºC in a 
humidified atmosphere. The adherent monolayers 
obtained were washed with pre-warmed PBS solution, 
and then 200 μl of Hank´s solution and 20 μl of latex 
beads (1.1 μm diluted to 1% PBS, Sigma-Aldrich) were 
added. After 30 min of incubation under the same 
conditions, the plates were washed, fixed with methanol 
(50%) and stained with Giemsa´s solution (Sigma-
Aldrich). The number of particles ingested by 100 
neutrophils or 100 macrophages was counted and this 
was expressed as Phagocytic Index.   
 
Natural killer cytotoxicity 
 
The natural killer (NK) cell cytotoxicity was evaluated 
following an enzymatic colorimetric assay (Cytotox 96 
TM Promega, Boeringher Ingelheim, Germany) based 
on the determination of lactate dehydrogenase (LDH) 
released by the cytolysis of targets cells (human K562 
lymphoma cells or murine YAC-1 lymphoma cells), 
using tetrazolium salts [25, 40].  The results were 
expressed as the percentage of tumor cells killed (% 
lysis). 
 
Lymphoproliferation 
 
The proliferation capacity of lymphocytes was 
evaluated by a standard method, previously described 
[25, 40]. The assay was assessed in both basal and 
stimulated conditions using mitogens [phytohema-
glutinin (PHA) and concanavaline A (Con A), for 
humans and mice, respectively]. Cells suspensions were 
dispensed into 96-wells plates (Costar, Cambridge, MA, 
USA). 20 μl/well of complete medium, PHA or Con A 
(1 μg/mL, Sigma-Aldrich) were added. After 48 h of 
incubation at 37ºC in a sterile and humidified 
atmosphere of 5% CO2, 2.5 μCi 3H-thymidine 
(Hartmann Analytic, Germany) were added to each 
well, followed by another incubation of 24 h. Cells were 
harvested in a semiautomatic harvester (Skatron 
Instruments, Norway) and thymidine uptake was 
measured in a beta counter (LKB, Upsala, Sweden) for 
1 min. The results were calculated as 3H-thymidine 
uptake (counts per minute, cpm) for basal and 
stimulated conditions, and were expressed as 
www.aging‐us.com  3117  AGING (Albany NY) 
lymphoproliferation capacity (%) giving 100% to the 
cpm in basal conditions. 
 
Statistical analysis 
 
SPSS 21.0 (SPSS, Chicago, USA) was used for the 
statistical analysis of the results. All data are expressed 
as the mean ± standard deviation (SD) of the values 
corresponding to subjects, being each value the mean of 
duplicate assays. The normality of the samples and the 
homogeneity of variances were checked by the 
Kolmogorov–Smirnov and Levene analyses, 
respectively. Differences due to age were studied 
through Student´s t test for independent samples. 
The Pearson correlation coefficient was used to test for 
correlation between parameters. Two-sided P<0.05 was 
considered the minimum level of significance. 
Differences in life span were studied through the 
Kaplan-Meier test, with a minimum significance level 
(log rank, Mantel-Cox) also set at P<0.05. 
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